retatrutide clinical trial results 2025 New Phase 3 data just dropped 👀 Eli Lilly's reported average weight loss approaching 30%, with some patients achieving historically associated with bariatric surgery. A few important caveats retatrutide side effects clinical trials

Taking into consideration all currently available data, GLP-2 might be much more promising than GLP-1

They all have FDA approval, which means that the medication has gone through extensive clinical trials to assess its efficacy and safety

Additional information

Are there any precautions to take before the first Ozempic injection

Ozempic rose from a 10 th place ranking among the 10 top-selling Part D drugs in 2021, with gross spending of $2.6 billion, to 6 th place in 2022, with spending of $4.6 billion (Figure 2)

Common gastrointestinal side effects (nausea, vomiting, diarrhoea) may temporarily reduce energy during the initial treatment phase